Diethylamine Salicylate

水杨酸二乙胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDiethylamine Salicylate
Drug Alias Name二乙胺水杨酸盐MultigesicMedalginanAlgibaumeMassagim +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainRheumatic DiseasesArthritis, Rheumatoid +[4] 
Global Approved IndicationsPainRheumatic Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date1992/12/31
Country/TerritoryCanadaUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesThornton & Ross LtdShanxi Liye Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPainRheumatic DiseasesArthritis, Rheumatoid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeM02AC
Related LinksWikipedia